Grounded methods
Anpac Bio has conducted its research studies in collaboration and partnership with several hospitals and medical institutions in the U.S and China.
Development and evaluation of cancer differentiation analysis technology: a novel biophysics-based cancer screening method: Expert Review of Molecular Diagnostics: Vol 0, No 0 (tandfonline.com)
Anpac-Bio-Abstract-Evaluation-of-a-Multi-Level-Multi-Parameter-Detection-Method-for-Digestive-System-Cancer-Diagnosis
Anpac-Bio-Abstract-Investigations-of-a-New-Diagnostics-Technology-for-Hepatocellular-Carcinoma-Screening
Anpac-Bio-Abstract-Investigations-of-an-Improved-Esophageal-Cancer-Diagnostics-Approach
Anpac-Bio-Abstract-Investigations-of-Breast-Cancer-Screening-Using-a-Novel-In-Vitro-Diagnostics-Technology
Anpac-Bio-Abstract-Investigations-on-Non-Small-Cell-Lung-Cancer-Screening
Cancer-differentiation-analysis-technology-as-a-novel-technology-for-cerebral-cancer-screening
Founded in 2008, Anpac Bio-Medical Science Co., Ltd. has brought together experts from biomedicine to nanotechnology.
Cancer Research & Detection
Chemistry & Bio-chemistry
Nano-technology & Physics
Surface & Material Science
Engineering & Manufacturing
Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.
Read the full article